A Response to the Letter to the Editor: "Bevacizumab Plus Atezolizumab in Pretreated Progressive and Metastatic Non-Small Cell Lung Cancer". Lee J, Ahn MJ. J Thorac Oncol 2022;17:e72-e73.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee J, Ahn MJ. A Response to the Letter to the Editor: "Bevacizumab Plus Atezolizumab in Pretreated Progressive and Metastatic Non-Small Cell Lung Cancer". J Thorac Oncol 2022;17:e72-e73.
PMID: 36031289